Dosage regimen of an S1P receptor agonist

Details for Australian Patent Application No. 2005309378 (hide)

Owner Novartis AG

Inventors Appel-Dingemanse, Silke; Kovarik, John M.

Agent Davies Collison Cave

Pub. Number AU-B-2005309378

PCT Pub. Number WO2006/058316

Priority 60/631,483 29.11.04 US

Filing date 28 November 2005

Wipo publication date 1 June 2006

Acceptance publication date 11 February 2010

International Classifications

A61K 31/135 (2006.01) - having aromatic rings, e.g. methadone

A61P 37/06 (2006.01) Drugs for immunological or allergic disorders

Event Publications

24 May 2007 PCT application entered the National Phase

  PCT publication WO2006/058316 Priority application(s): WO2006/058316

11 February 2010 Application Accepted

  Published as AU-B-2005309378

10 June 2010 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005309381-Hearing protector

2005309365-Modulators of muscarinic receptors